Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer

References

• Long N, Moore MA, Chen W, Gao CM, Lai MS, Mizoue T, Oyunchimeg D, Park S, Shin HR, Tajima K, Yoo KY, Sobue T. Cancer epidemiology and control in North-East Asia past, present and future. Asian Pac J Cancer Prev 2010;11:107–48.
   PubMedGoogle Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Luukkaa H, Klemi P, Leivo I, Mäkitie AA, Irish J, Gilbert R, Perez-Ordonez B, Hirsimäki P, Vahlberg T, Kivisaari A, Kähäri VM, Grénman R. Expression of matrix metalloproteinases -1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer. Head Neck 2010;32:1019–27.
   PubMed Web of Science ®Google Scholar
• Klinge U, Rosch R, Junge K, Krones CJ, Stumpf M, Lynen-Jansen P, Mertens PR, Schumpelick V. Different matrix micro-environments in colon cancer and diverticular disease. Int J Colorectal Dis 2007;22:515–20.
   Google Scholar
• Mak IW, Turcotte RE, Popovic S, Singh G, Ghert M. AP-1 as a regulator of MMP-13 in the stromal cell of giant cell tumor of bone. Biochem Res Int 2011;2011:164–197.
   Google Scholar
• Yongming Li, Lin Tang, Yinzhong Duan, Yin Ding. Upregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells. BMC Res Notes 2010;3:309–16.
   Google Scholar
• Gordana Konjevi, Sandra Stankovi. Matrix metalloproteinases in the process of invasion and metastasis of breast cancer. Arch Oncol 2006;14:136–40.
   Google Scholar
• Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9–10.
   PubMed Web of Science ®Google Scholar
• Lemaitre V, D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006;78:1–10.
   PubMedGoogle Scholar
• Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544–50.
   PubMed Web of Science ®Google Scholar
• Deng SJ, Bickett DM, Mitchell JL, Lambert MH, Blackburn RK, Carter HL, Neugebauer J, Pahel G, Weiner MP, Moss ML. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library. J Biol Chem 2000;275:31422–27.
   PubMed Web of Science ®Google Scholar
• Tardif G, Reboul P, Pelletier JP, Martel-Pelletier J. Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Mod Rheumatol 2004;14:197–204.
   PubMedGoogle Scholar
• Davis NC, Evans EB, Cohen JR, Theile DE. Staging of colorectal cancer, the Australian clinico-pathological staging (ACPS) system compared with Dukes’ system. Dis Colon Rectum 1984;27:707–13.
   PubMed Web of Science ®Google Scholar
• O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127:813–20.
   PubMedGoogle Scholar
• Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002;3:207–14.
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463–516.
   PubMed Web of Science ®Google Scholar
• Lafleur MA, Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 2003;5:1–39.
   PubMedGoogle Scholar
• Ala-aho R, Ahonen M, George SJ, Heikkilä J, Grénman R, Kallajoki M, Kähäri VM. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo. Oncogene 2004;23:5111–23.
   PubMedGoogle Scholar
• Lafleur MA, Drew AF, de Sousa EL, Blick T, Bills M, Walker EC, Williams ED, Waltham M , Thompson EW. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer 2005;114:544–54.
   PubMed Web of Science ®Google Scholar
• Culhaci N, Metin K, Copcu E, Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. BMC Cancer 2004;4:42.
   PubMedGoogle Scholar
• Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621–30.
   PubMed Web of Science ®Google Scholar
• Itoh Y, Nagase H. Matrix metalloproteinases in cancer. Essays Biochem 2002;38:21–36.
   PubMed Web of Science ®Google Scholar
• Yu AE, Hewitt RE, Connor EW, Stetler WG. Matrix metalloproteinases, novel targets for directed cancer therapy. Drugs Aging 1997;11:229–44.
   PubMed Web of Science ®Google Scholar
• Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002;70:561–73.
   PubMed Web of Science ®Google Scholar
• Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 2008;8:83–92.
   Google Scholar
• Pei Y, Harvey A, Yu XP, Chandrasekhar S, Thirunavukkarasu K. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthritis Cartilage 2006;14:749–58.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep 2009;22:1119–27.
   PubMed Web of Science ®Google Scholar
• Hellman NE, Spector J, Robinson J, Zuo X, Saunier S, Antignac C, Tobias JW, Lipschutz JH. Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J Biol Chem 2008;283:4272–82.
   Google Scholar
• Lederle W, Hartenstein B, Meides A, Kunzelmann H, Werb Z, Angel P. MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 2010;31:1175–84.
   PubMed Web of Science ®Google Scholar
• Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 2004;10:8229–34.
   PubMed Web of Science ®Google Scholar
• Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 2002;55:758–62.
   PubMedGoogle Scholar
• Leeman MF, Curran S, Murray GI. The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 2002;37:149–66.
   PubMed Web of Science ®Google Scholar
• Lyall MS, Dundas SR, Curran S, Murray GI. Profiling markers of prognosis in colorectal cancer. Clin Cancer Res 2006;12:1184–91.
   PubMed Web of Science ®Google Scholar